Diagnostic performance of automated plasma amyloid-β assays combined with pre-analytical immunoprecipitation

BACKGROUND: Measurements of the amyloid-β (Aβ) 42/40 ratio in blood plasma may support the early diagnosis of Alzheimer’s disease and aid in the selection of suitable participants in clinical trials. Here, we compared the diagnostic performance of fully automated prototype plasma Aβ42/40 assays with...

Descripción completa

Detalles Bibliográficos
Autores principales: Klafki, Hans-W., Vogelgsang, Jonathan, Manuilova, Ekaterina, Bauer, Chris, Jethwa, Alexander, Esselmann, Hermann, Jahn-Brodmann, Anke, Osterloh, Dirk, Lachmann, Ingolf, Breitling, Benedict, Rauter, Carolin, Hansen, Niels, Bouter, Caroline, Palme, Stefan, Schuchhardt, Johannes, Wiltfang, Jens
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9450259/
https://www.ncbi.nlm.nih.gov/pubmed/36071505
http://dx.doi.org/10.1186/s13195-022-01071-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9450259/
https://www.ncbi.nlm.nih.gov/pubmed/36071505
http://dx.doi.org/10.1186/s13195-022-01071-y

Ejemplares similares